IRIDEX is an ophthalmic medical technology company that develops and commercializes laser systems and delivery devices for treating glaucoma and retinal diseases. The company's core offerings include proprietary MicroPulse® laser consoles (such as Cyclo G6® and IQ 532®), delivery devices like slit lamp adapters and scanning laser systems, and single-use disposable probes that enable low-energy, tissue-sparing laser therapy with greater precision than traditional continuous-wave laser treatments. IRIDEX sells to ophthalmologists in hospital operating rooms, ambulatory surgical centers, and office clinics through direct sales forces in the U.S. and Germany and via independent distributors internationally, generating recurring revenue from consumable probe sales and service contracts for laser systems.